Role of MRI in Assessment of the Urinary Bladder Wall Post Transurethral Tumor Resection

NCT05787938 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2023-03-28

No results posted yet for this study

Summary

To study the feasibility of using magnetic resonance imaging (MRI) in evaluation UB wall thickening after transurethral resection (TUR) of bladder cancer.

Conditions

  • Urinary Bladder Cancer

Interventions

DEVICE

MRI

A procedure that uses radio waves, a powerful magnet, and a computer to make a series of detailed pictures of areas inside the body. A contrast agent, such as gadolinium, may be injected into a vein to help the tissues and organs show up more clearly in the picture. MRI may be used to help diagnose disease, plan treatment, or find out how well treatment is working. It is especially useful for imaging the brain and spinal cord, the heart and blood vessels, the bones, joints, and other soft tissues, the organs in the pelvis and abdomen, and the breast. Also called magnetic resonance imaging, NMRI, and nuclear magnetic resonance imaging.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Amr Farouk Muorad, Prof.Doctor · Assiut University

  • Mohamed Moamen Elbaroudy, doctor · Assiut University

Eligibility

Min Age
40 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2024-04-01
Completion
2024-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05787938 on ClinicalTrials.gov